Annual Accounts Payable
$6.46 M
+$808.00 K+14.28%
31 December 2023
Summary:
Leap Therapeutics annual accounts payable is currently $6.46 million, with the most recent change of +$808.00 thousand (+14.28%) on 31 December 2023. During the last 3 years, it has risen by +$3.75 million (+137.95%). LPTX annual accounts payable is now at all-time high.LPTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$5.95 M
-$1.86 M-23.86%
30 September 2024
Summary:
Leap Therapeutics quarterly accounts payable is currently $5.95 million, with the most recent change of -$1.86 million (-23.86%) on 30 September 2024. Over the past year, it has increased by +$47.00 thousand (+0.80%). LPTX quarterly accounts payable is now -25.36% below its all-time high of $7.97 million, reached on 30 September 2021.LPTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.3% | +0.8% |
| 3 y3 years | +137.9% | -25.4% |
| 5 y5 years | +80.6% | +21.6% |
LPTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.9% | -25.4% | +41.9% |
| 5 y | 5 years | at high | +137.9% | -25.4% | +133.4% |
| alltime | all time | at high | >+9999.0% | -25.4% | +9647.5% |
Leap Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.95 M(-23.9%) |
| June 2024 | - | $7.81 M(+31.2%) |
| Mar 2024 | - | $5.95 M(-8.0%) |
| Dec 2023 | $6.46 M(+14.3%) | $6.46 M(+9.6%) |
| Sept 2023 | - | $5.90 M(-9.2%) |
| June 2023 | - | $6.50 M(+18.2%) |
| Mar 2023 | - | $5.50 M(-2.8%) |
| Dec 2022 | $5.66 M(+35.0%) | $5.66 M(-9.9%) |
| Sept 2022 | - | $6.28 M(-16.9%) |
| June 2022 | - | $7.55 M(+76.2%) |
| Mar 2022 | - | $4.29 M(+2.3%) |
| Dec 2021 | $4.19 M(+54.2%) | $4.19 M(-47.4%) |
| Sept 2021 | - | $7.97 M(+83.4%) |
| June 2021 | - | $4.34 M(+23.6%) |
| Mar 2021 | - | $3.51 M(+29.3%) |
| Dec 2020 | $2.72 M(-40.6%) | $2.72 M(+6.7%) |
| Sept 2020 | - | $2.55 M(-6.2%) |
| June 2020 | - | $2.72 M(-44.9%) |
| Mar 2020 | - | $4.93 M(+7.9%) |
| Dec 2019 | $4.57 M | $4.57 M(-6.5%) |
| Sept 2019 | - | $4.89 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $5.33 M(+61.5%) |
| Mar 2019 | - | $3.30 M(-7.9%) |
| Dec 2018 | $3.58 M(+36.5%) | $3.58 M(-13.7%) |
| Sept 2018 | - | $4.15 M(-12.9%) |
| June 2018 | - | $4.77 M(+15.4%) |
| Mar 2018 | - | $4.13 M(+57.5%) |
| Dec 2017 | $2.62 M(-18.7%) | $2.62 M(+0.9%) |
| Sept 2017 | - | $2.60 M(-15.9%) |
| June 2017 | - | $3.09 M(+10.6%) |
| Mar 2017 | - | $2.79 M(-13.4%) |
| Dec 2016 | $3.23 M(+57.5%) | $3.23 M(+458.9%) |
| June 2016 | - | $577.00 K(-71.8%) |
| Dec 2015 | $2.05 M(+3257.4%) | $2.05 M(-25.2%) |
| Sept 2015 | - | $2.74 M(-2.5%) |
| June 2015 | - | $2.81 M(-0.4%) |
| Mar 2015 | - | $2.82 M(+4524.6%) |
| Dec 2014 | $61.00 K(-94.4%) | $61.00 K(-96.9%) |
| Sept 2014 | - | $1.97 M(-38.3%) |
| June 2014 | - | $3.19 M(+16.4%) |
| Mar 2014 | - | $2.75 M(+150.8%) |
| Dec 2013 | $1.09 M(+275.0%) | $1.09 M |
| Dec 2012 | $292.00 K | - |
FAQ
- What is Leap Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Leap Therapeutics?
- What is Leap Therapeutics annual accounts payable year-on-year change?
- What is Leap Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Leap Therapeutics?
- What is Leap Therapeutics quarterly accounts payable year-on-year change?
What is Leap Therapeutics annual accounts payable?
The current annual accounts payable of LPTX is $6.46 M
What is the all time high annual accounts payable for Leap Therapeutics?
Leap Therapeutics all-time high annual accounts payable is $6.46 M
What is Leap Therapeutics annual accounts payable year-on-year change?
Over the past year, LPTX annual accounts payable has changed by +$808.00 K (+14.28%)
What is Leap Therapeutics quarterly accounts payable?
The current quarterly accounts payable of LPTX is $5.95 M
What is the all time high quarterly accounts payable for Leap Therapeutics?
Leap Therapeutics all-time high quarterly accounts payable is $7.97 M
What is Leap Therapeutics quarterly accounts payable year-on-year change?
Over the past year, LPTX quarterly accounts payable has changed by +$47.00 K (+0.80%)